Haematopoiesis

Revision as of 15:46, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Jump to navigation Jump to search

WikiDoc Resources for Haematopoiesis

Articles

Most recent articles on Haematopoiesis

Most cited articles on Haematopoiesis

Review articles on Haematopoiesis

Articles on Haematopoiesis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Haematopoiesis

Images of Haematopoiesis

Photos of Haematopoiesis

Podcasts & MP3s on Haematopoiesis

Videos on Haematopoiesis

Evidence Based Medicine

Cochrane Collaboration on Haematopoiesis

Bandolier on Haematopoiesis

TRIP on Haematopoiesis

Clinical Trials

Ongoing Trials on Haematopoiesis at Clinical Trials.gov

Trial results on Haematopoiesis

Clinical Trials on Haematopoiesis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Haematopoiesis

NICE Guidance on Haematopoiesis

NHS PRODIGY Guidance

FDA on Haematopoiesis

CDC on Haematopoiesis

Books

Books on Haematopoiesis

News

Haematopoiesis in the news

Be alerted to news on Haematopoiesis

News trends on Haematopoiesis

Commentary

Blogs on Haematopoiesis

Definitions

Definitions of Haematopoiesis

Patient Resources / Community

Patient resources on Haematopoiesis

Discussion groups on Haematopoiesis

Patient Handouts on Haematopoiesis

Directions to Hospitals Treating Haematopoiesis

Risk calculators and risk factors for Haematopoiesis

Healthcare Provider Resources

Symptoms of Haematopoiesis

Causes & Risk Factors for Haematopoiesis

Diagnostic studies for Haematopoiesis

Treatment of Haematopoiesis

Continuing Medical Education (CME)

CME Programs on Haematopoiesis

International

Haematopoiesis en Espanol

Haematopoiesis en Francais

Business

Haematopoiesis in the Marketplace

Patents on Haematopoiesis

Experimental / Informatics

List of terms related to Haematopoiesis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Haematopoiesis (from Ancient Greek: haima blood; poiesis to make) (or hematopoiesis in the United States; sometimes also haemopoiesis or hemopoiesis) is the formation of blood cellular components. All of the cellular components of the blood are derived from haematopoietic stem cells. The term multipotent refers to the ability of a cell to become several different types of cell (but not all types in a germ layer). Multipotent haematopoietic cells can become any type of cell in the blood system. The multipotent cells determine what type of cell to become, or differentiate, in a step-wise fashion. It normally goes at a speed of 1011–1012 cells per day [1]

Simple diagram that shows the development of different blood cells from hematopoietic stem cell to mature cells


Lineages

All blood cells are divided into three lineages.

Comprehensive diagram that shows the development of different blood cells from hematopoietic stem cell to mature cells


Granulopoiesis

Granulopoiesis (or granulocytopoiesis) is hematopoiesis of granulocytes.

It occurs primarily within bone marrow.

It involves the following stages:

Locations

In developing embryos, blood formation occurs in aggregates of blood cells in the yolk sac, called blood islands. As development progresses, blood formation occurs in the spleen, liver and lymph nodes. When bone marrow develops, it eventually assumes the task of forming most of the blood cells for the entire organism. However, maturation, activation, and some proliferation of lymphoid cells occurs in secondary lymphoid organs (spleen, thymus, and lymph nodes). While most haematopoiesis in adults occurs in the marrow of the long bones such as the femurs, it also occurs in spongy bone like ribs and sternum).

Extramedullary

In some cases, the liver, thymus, and spleen may resume their haematopoietic function, if necessary. This is called extramedullary haematopoiesis. It may cause these organs to increase in size substantially. [1]

Other vertebrates

In some vertebrates, haematopoiesis can occur wherever there is a loose stroma of connective tissue and slow blood supply, such as the gut, spleen, kidney or ovaries.

Maturation

As a stem cell matures it undergoes changes in gene expression (the extent by which a gene exerts influence on its target changes) that limit the cell types that it can become and move it closer to a specific cell type. These changes can often be tracked by monitoring the presence of proteins on the surface of the cell. Each successive change moves the cell closer to its final choice of cell type and further limits its potential cell type until it is fully differentiated. This process is usually presented as a dendrogram or decision tree, which starts with a stem cell at the single starting point, and branches for the major lineages that branch into intermediate semi-differentiated cell types, and eventually, to fully differentiated cells.

Determination

It seems like it's the location of blood cells that makes the cell determination and not vice versa (i.e. e.g. that a hematopoietic stem cell determined to differentiate into a specific cell type would end up at a destined location). For instance, the thymus provides an environment for thymocytes to differentiate into a variety of different functional T cells.

For the stem cells and other undifferentiated blood cells in the bone marrow, the determination is generally explained by the determinism theory of hematopoiesis, saying that colony stimulating factors and other factors of the hematopoietic microenvironment determine the cells to follow a certain path of cell differentiation. This is the classical way of describing hematopoiesis. In fact, however, it is not really true. The ability of the bone marrow to regulate the quantity of different cell types to be produced is more accurately explained by a stochastic theory: Undifferentiated blood cells are determined to specific cell types by randomness. The hematopoietic microenvironment avails some of the cells to survive and some, on the other hand, to perform apoptosis. By regulating this balance between different cell types, the bone marrow can alter the quantity of different cells to ultimately be produced.

Haematopoietic growth factors

Red and white blood cell production is regulated with great precision in healthy humans, and the production of granulocytes is rapidly increased during infection. The proliferation and self-renewal of these cells depend on stem cell factor (SCF). Glycoprotein growth factors regulate the proliferation and maturation of the cells that enter the blood from the marrow, and cause cells in one or more committed cell lines to proliferate and mature. Three more factors which stimulate the production of committed stem cells are called colony-stimulating factors (CSFs) and include granulocyte-macrophage CSF (GM-CSF), granulocyte CSF (G-CSF) and macrophage CSF (M-CSF). These stimulate a lot of granulocyte formation. They are active on either progenitor cells or end product cells.

Erythropoietin is required for a myeloid progenitor cell to become an erythrocyte. [2] On the other hand, thrombopoietin makes myeloid progenitor cells differentiate to megakaryocytes (thrombocyte-forming cells).[2]

Examples of cytokines and the blood cells they give rise to, is shown in the picture below.

Diagram including some of the important cytokines that determine which type of blood cell will be created.[2] SCF= Stem Cell Factor Tpo= Thrombopoietin IL= Interleukin GM-CSF= Granulocyte Macrophage-colony stimulating factor Epo= Erythropoietin M-CSF= Macrophage-colony stimulating factor G-CSF= Granulocyte-colony stimulating factor SDF-1= Stromal cell-derived factor-1 FLT-3 ligand= FMS-like tyrosine kinase 3 ligand TNF-a = Tumor necrosis factor-alpha TGFβ = Transforming growth factor beta


Transcription factors

Growth factors initiate signal transduction pathways, altering transcription factors, that, in turn activate genes that determines the differentiation of blood cells.

The early committed progenitors express low levels of transcription factors that may commit them to discrete cell lineages. Which cell lineage is selected for differentiation may depend both on chance and on the external signals received by progenitor cells. Several transcription factors have been isolated that regulate differentiation along the major cell lineages. For instance, PU.1 commits cells to the myeloid lineage whereas GATA-1 has an essential role in erythropoietic and megakaryocytic differentiation.

Extramedullary hematopoiesis in a thalassemia patient

See also

References

  1. 1.0 1.1 Semester 4 medical lectures at Uppsala University 2008 by Leif Jansson
  2. 2.0 2.1 2.2 Molecular cell biology. Lodish, Harvey F. 5. ed. : - New York : W. H. Freeman and Co., 2003, 973 s. b ill. ISBN 0-7167-4366-3

External links

Template:Hematology

cs:Krvetvorba de:Hämatopoese nl:Hematopoëse sv:Hematopoes


Template:WikiDoc Sources